<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In continuation to our studies toward the identification of direct anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) HT29, SW480 and HCT116 cells </plain></SENT>
<SENT sid="1" pm="."><plain>Additionally, DB induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased pro-apoptotic Bax </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, DB attenuated Wnt-signaling by downregulation of β-catenin, Tcf4 and β-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of β-catenin target genes cyclin D1, c-myc and survivin </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities </plain></SENT>
<SENT sid="4" pm="."><plain>We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-α, JNK, NF-κB, c-Jun and c-Fos while increased that of IκBα </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, we demonstrated that DB inhibited <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in HT29 xenograft mice using non-invasive bioluminescence technique </plain></SENT>
<SENT sid="6" pm="."><plain>Consistently, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples from DB-treated mice demonstrated suppressed expression of β-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression </plain></SENT>
<SENT sid="7" pm="."><plain>Collectively, our data supports DB as an inhibitor of Wnt/β-catenin/Tcf signaling pathway that may be beneficial in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> management </plain></SENT>
</text></document>